Methylenetetrahydrofolate reductase polymorphism (677 C>T) predicts long time to progression in metastatic colon cancer treated with 5-fluorouracil and folinic acid.
about
Single Nucleotide Polymorphisms as Prognostic and Predictive Factors of Adjuvant Chemotherapy in Colorectal Cancer of Stages I and IIPersonalized medicine and cancer.Pharmacogenetic variants in the DPYD, TYMS, CDA and MTHFR genes are clinically significant predictors of fluoropyrimidine toxicityCan GSTM1 and GSTT1 polymorphisms predict clinical outcomes of chemotherapy in gastric and colorectal cancers? A result based on the previous reports.The effects of genomic polymorphisms in one-carbon metabolism pathways on survival of gastric cancer patients received fluorouracil-based adjuvant therapy.Pharmacogenomics and metastatic colorectal cancer: current knowledge and perspectives.Role of depth of response and MTHFR genotype as predictors of fluorouracil rechallenge therapy for refractory metastatic colorectal cancer.Polymorphisms of MTHFR C677T and A1298C associated with survival in patients with colorectal cancer treated with 5-fluorouracil-based chemotherapy.Concordance of genotype for polymorphisms in DNA isolated from peripheral blood and colorectal cancer tumor samples.Germline TYMS genotype is highly predictive in patients with metastatic gastrointestinal malignancies receiving capecitabine-based chemotherapy.Detection of polymorphism in the methlyenetetrahydrofolate reductase gene by Raman spectroscopy
P2860
Q26765344-43C2CB45-9524-4D30-992C-8CE4EC1EC37FQ34608577-4852B235-0910-405E-A8E8-DAB13DC20985Q36959145-5D233008-487F-4EC1-A7B3-7ACEBAD58747Q37042575-49BBE89F-83FE-4B1E-A81E-BFAF4E7F4E52Q37125346-5C8B14AE-A267-4D43-BAD9-6CF952929B03Q37969851-227B290C-6B9E-43C3-8709-F11998358D58Q38637985-907457D4-7651-4599-ADED-736B1BEA1819Q39043677-BCD6AE1E-E63B-4282-AF9C-F3D7EA475773Q39307013-E21911FF-910D-4B50-A24C-5B03694B3F41Q41442402-1A6E86BC-F8EC-44BA-B2F3-9B3B7670AEB8Q57652115-D7664933-8961-4A78-B21C-57B04074FF1A
P2860
Methylenetetrahydrofolate reductase polymorphism (677 C>T) predicts long time to progression in metastatic colon cancer treated with 5-fluorouracil and folinic acid.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Methylenetetrahydrofolate redu ...... fluorouracil and folinic acid.
@en
type
label
Methylenetetrahydrofolate redu ...... fluorouracil and folinic acid.
@en
prefLabel
Methylenetetrahydrofolate redu ...... fluorouracil and folinic acid.
@en
P2093
P1476
Methylenetetrahydrofolate redu ...... -fluorouracil and folinic acid
@en
P2093
Alberto Serrano
Aldo Bauza
Clementina Castro
Germán Calderillo
Luis A Herrera
Omar Castillo-Fernández
Roberto Herrera
P304
P356
10.1016/J.ARCMED.2010.08.011
P577
2010-08-01T00:00:00Z